This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van Saene, J.J.M. Articles by Ramsay, G. Search for Related Content PubMed Articles by van Saene, J.J.M. Articles by Ramsay, G. Social Bookmarking                         What's this?

Reduction of the intestinal endotoxin pool by three different SDD regimens in human volunteers

Laboratory for Pharmaceutical Technology and Dispensing, University of Groningen, Groningen, The Netherlands

C.P. Stoutenbeek

Intensive Care Unit, Academic Medical Centre, Amsterdam, The Netherlands

H.K.F. van Saene

Department of Medical Microbiology, University of Liverpool, Liverpool, UK

G. Matera

Department of Medical Microbiology, University of Reggio Calabria, Catanzaro, Italy

A.E. Martinez-Pellus

Department of Intensive Care, University Hospital 'Virgen de la Arrixaca', Alicante, Spain

G. Ramsay

Department of Surgery, University Hospital Maastricht, Maastricht, The Netherlands

Aerobic Gram-negative bacilli (AGNB) carried in the gut by healthy individuals generate 1 mg of 'physiological' endotoxin per g of faeces. Successful eradication of AGNB from the gut would be expected to lead to a lowering of the intestinal endotoxin pool. This prompted us to evaluate the reduction of intestinal endotoxin in 6 healthy volunteers who each received 3 different oral antibiotic regimens. Regimen 1 was polymyxin E (600 mg/day), regimen 2 polymyxin E (400 mg/day) combined with tobramycin (320 mg/day) and regimen 3 pefloxacin (800 mg/day). Each regimen was separated by an antibiotic free period of 3 months. A faecal sample (minimally 2 g) was obtained from each volunteer, before treatment began and afterwards 3 times a week on alternating days (Monday, Wednesday, Friday) for 3 weeks. Each volunteer produced 30 samples, 10 each per oral antibiotic. The samples were serially diluted in nutrient broth for the colony count of AGNB, whilst endotoxin was measured using the classical Limulus amoebocyte lysate micro-assay. The base-line value of faecal AGNB was 10 ^3-4 colony forming units/g of faeces. All samples obtained on day 3 following antibiotic intake were negative for AGNB, and remained negative during antibiotic intake. The AGNB free carrier state was associated with a reduction in gut endotoxin. The reduction was approximately 10 ng (1 log) for polymyxin E and pefloxacin, whilst the combination of polymyxin/tobramycin significantly reduced the intestinal endotoxin concentrations from 1 mg to 100 ng in the gut; a reduction of 10⁴. Although AGNB were killed by the three regimens, the 'free' endotoxin left in the gut was effectively neutralised by the combination polymyxin/tobramycin only. From a clinical point of view, gut-derived endotoxaemia may play a role in the systemic inflammatory response syndrome and hence the outcome, in critically ill intensive care patients. This study supports other work which indicates that mortality is significantly reduced in only those intensive care patients who received oral polymyxin/tobramycin.

Innate Immunity, Vol. 3, No. 4, 337-343 (1996)
DOI: 10.1177/096805199600300408


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				V. M. Conraads, P. G. Jorens, L. S. De Clerck, H. K. Van Saene, M. M. Ieven, J. M. Bosmans, A. Schuerwegh, C. H. Bridts, F. Wuyts, W. J. Stevens, et al. Selective intestinal decontamination in advanced chronic heart failure: a pilot trial Eur J Heart Fail, June 1, 2004; 6(4): 483 - 491. [Abstract] [Full Text] [PDF]